ArticleInternational journal of cancer2019

Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1.

Maria Laura Falchetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.